Videos

Cathy Belt, RN, MSN, AOCN, Abramson Cancer Center of the University of Pennsylvania, discusses possible steps individuals can take upon finding out they have an inherited cancer syndrome, such as mutations in the BRCA1 or BRCA2 genes.

Maureen E. Thyne, RPA-C, Weill Cornell Medical College, discusses the impact that ruxolitinib (Jakafi) has had on patients with myelofibrosis.

Melissa L. Bondy, PhD, MS, associate director for cancer prevention and population sciences at Baylor College of Medicine, discusses the importance of finding genetic mutations that can cause cancers such as glioma.

Jeffrey Weber, MD, PhD, deputy director of the Perlmutter Cancer Center, NYU Langone Medical Center, discusses the role of the oncology nurse when treating patients who have cancer with checkpoint inhibitors.

Arvind Shinde, MD, MBA, MPH, assistant clinical professor at Cedars-Sinai Medical Center, discusses the potential benefits of monitoring patients with fitness trackers.

Richard Essner, MD, co-director Melanoma Program, Cedars-Sinai Medical Center, discusses the nurse’s role in managing wounds after a patient undergoes surgery for melanoma.

Michael Birrer, MD, PhD, Harvard Medical School, discusses what he hopes to discover as factors that influence long-term survival in patients and survivors with ovarian cancer.

Grant Williams, MD, clinical instructor and research fellow at the University of North Carolina, Chapel Hill, discusses sarcopenia in patients with cancer.

Jennifer Levine, MD, Columbia University Medical Center, discusses fertility issues that adult survivors of childhood cancer often face.

Nickhill Bhakta, MD, fellow at St. Jude Children’s Research Hospital, discusses some unanswered questions about late effects of adult survivors of childhood cancer.

Fay J. Hlubocky, PhD, MA, University of Chicago Department of Medicine, discusses the concerns about death that young adult survivors face.

Dave Dubin, founder of AliveAndKickn, discusses the importance of healthcare professionals knowing when to test for Lynch syndrome.

Kathryn H. Schmitz, PhD, MPH, professor of Public Health Sciences and associate director of Population Sciences at the Penn State Cancer Institute, discusses benefits that can be reaped from running parallel mouse and human studies.

Olga Ivanov, MD, surgeon at the Florida Hospital Cancer Institute, discusses survivorship in breast cancer.

Dmitriy Zamarin, MD, PhD, assistant attending physician at Memorial Sloan Kettering Cancer Center, discusses side effects that nurses should look our for when treating patients with the T-VEC virus.

Tara Sanft, MD, Yale Cancer Center, discusses decreasing VEGF levels through exercise and diet to prevent breast cancer recurrence.

Matthew Galsky, MD, medical oncologist, Icahn School of Medicine at Mount Sinai, discusses treating different subsets of bladder cancer.

Carlos Rodriguez-Galindo, MD, chair of the Department of Global Pediatric Medicine and director of the International Outreach Program at St. Jude Children’s Research Hospital, and chair of the rare tumor committee at the Children’s Oncology Group, talks about the role rare cancer research has in advancing cancer care as a whole.

Bernardo L. Rapoport, MD, the Medical Oncology Centre of Rosebank, discusses how chemotherapy-induced nausea and vomiting (CINV) is an unmet need in cancer care.

Robert Pirka, MD, Medical University of Vienna, discusses the role that nurses can play in making patients feel more comfortable about enrolling in a lung cancer clinical trial.

Melisa Wong, MD, Oncology Chief Fellow, Hematology/Oncology, Aging Research T32 Fellow, University of California San Francisco Geriatrics, discusses the impact that comorbidities have on the treatment for lung cancer.

Ignacio I. Wistuba, MD, chair of the department of Translational Molecular Pathologies at MD Anderson Cancer Center, discusses the role nurses play in the field of molecular testing.

Jennifer Temel, MD, director of the Cancer Outcomes Research Program at Massachusetts General Hospital, discusses the benefits that palliative care can have not only on patients, but on their caregivers as well.

Yuhong Dong, MD, PhD, clinical researcher at Novartis, discusses the benefits of practicing Falun Gong for patients with terminal cancer.

Kaitlyn Francese, RN, a research nurse at NYU Langone Medical Center, discusses the difficulty she faces in getting patients on clinical trials to talk about their side effects.

Shi-Yi Wang, MD, PhD, assistant professor of Epidemiology at Yale School of Public Health, discusses the need for change in aggressive end-of-life cancer treatment.

​Mark E. Robson, MD, Clinical Director of the Clinical Genetics Services at Memorial Sloan Kettering Cancer Center, discusses when it is appropriate to go for genetic testing to determine cancer risk.